Introduction of antigens by the oral route in adult animals induces a state of antigen-specific non-responsiveness. The mechanism by which this non-responsiveness is mediated is not well understood, however, increasing evidence suggests that the state of non-responsiveness is mediated by clonal anergy and/or by the induction of antigen-specific regulatory T cells. In murine models of experimental allergic encephalomyelitis, oral administration of myelin basic protein (MBP) in adults induces antigen- specific T cells that mediate their effector functions by producing suppressive cytokines. The repertoire of T cells induced following oral administration of an antigen has not been defined. Furthermore, the antigenic epitopes (helper, anergizing or regulatory) that are generated following oral feeding of an antigen, their MHC binding characteristics and the mechanism by which they mediate protection have not been defined. In contrast to oral tolerization in adults, our preliminary results suggest that oral feeding of an antigen in neonates results in immunological priming leading to enhanced immune responses to the antigen as an adult. However, the cellular and molecular mechanisms responsible for such contradictory effects are also not clear. The primary goal of this portion of the program project is to define the antigenic epitopes that are generated by antigen processing and presentation via the gut and study the T cell responses to these epitopes in adults and in neonates. We propose to: 1) identify epitopes and define the repertoire of T cells induced following oral administration of MBP in adult mice. This will be accomplished by generating T cell clones and hybridomas from orally tolerized mice which will be used as tools to define: A) tolerogenic epitopes; B) diversity of the T cell repertoire including T cell receptor usage; C) MHC requirement of these cells and D) to identify gut associated antigen presenting cells 2) study the effect of oral administration of MBP in neonates on the development and selection of helper vs. regulatory T cell repertoire. Neonates will be fed with the antigen and then tested as adults to determine whether oral administration of antigen specifically A) deletes antigen-specific regulatory cells or b) preferentially selects and expands the antigen-reactive helper/encephalitogenic T cell repertoire. The mechanisms of neonatal priming will be further studied in the MBP-specific T cell receptor transgenic mice. Furthermore, the results on the epitopes and T cell repertoire generated by oral feeding of the neonates will be directly compared with adults fed the same antigen. These studies will provide broad basic information regarding the mechanism by which oral administration of antigen mediates non-responsiveness in the adult and will provide better understanding of the cells and epitopes that are involved in mediating oral tolerance. The studies on immunological priming mediated by orally administered antigen in neonates may also provide an insight into the cellular and immunological mechanisms responsible for food allergies.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Kipp, B; Bar-Or, A; Gausling, R et al. (2000) A novel population of B7-1+ T cells producing intracellular IL-4 is decreased in patients with multiple sclerosis. Eur J Immunol 30:2092-100
Scholz, C; Patton, K T; Anderson, D E et al. (1998) Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol 160:1532-8
Pohl-Koppe, A; Burchett, S K; Thiele, E A et al. (1998) Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. J Neuroimmunol 91:19-27
Liu, L; Rich, B E; Inobe, J et al. (1998) Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4. Int Immunol 10:1017-26
Chen, Y; Hancock, W W; Marks, R et al. (1998) Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice. J Neuroimmunol 82:149-59
Inobe, J; Slavin, A J; Komagata, Y et al. (1998) IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 28:2780-90
Gonnella, P A; Chen, Y; Inobe, J et al. (1998) In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J Immunol 160:4708-18
Pohl-Koppe, A; Balashov, K E; Steere, A C et al. (1998) Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol 160:1804-10
Greenfield, E A; Howard, E; Paradis, T et al. (1997) B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. J Immunol 158:2025-34
Hafler, D A; Kent, S C; Pietrusewicz, M J et al. (1997) Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis. Ann N Y Acad Sci 835:120-31

Showing the most recent 10 out of 16 publications